Trial intelligence / Profile preview

Remimazolam for prevention of emergence agitation in children after general anesthesia

jRCTs051240010Recruiting

Start
Jun 2024
Modality
Small Molecules
Countries
1
01

Overview

Single-arm trial of remimazolam in Emergence agitation (EA). Primary endpoint: Maximum Pediatric Anesthesia Emergence Delirium score. Started Jun 2024; status: recruiting.

02

Drugs

remimazolam
03

Conditions

Emergence agitation (EA)

Beyond the preview

Go deeper on jRCTs051240010.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs051240010.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call